Advancing the Development of Pediatric Therapeutics (ADEPT 7)


Advancing the Development of Pediatric Therapeutics (ADEPT 7)

Collaborative workshop hosted by the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) and the Food and Drug Administration (FDA)

Wednesday, September 1 - Thursday, September 2, 2021

Access Meeting Information (speaker slides, meeting recordings, etc.)

About the Event:

This workshop will highlight key aspects of the new guideline.  The workshop will discuss methodological considerations and cases will be presented to exemplify various concepts.  The session will allow for an open dialogue between regulators, academic researchers, and drug developers.

This virtual workshop will be open to the public. 

Adobe Connect Link:
To view the webinar, please visit:
Enter your Name (bottom left) & click "Enter Room" 

Questions? Contact Ann Anonsen

This workshop is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD005946 totaling $25,000 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.


Speaker Bios

M-CERSI Event Page